Answers are grounded in this paper and cite their sources.
Demonstrates that targeting S100A2 improves chemotherapy efficacy in oral cancer, suggesting a new treatment approach.
These findings position S100A2 as a potential therapeutic target for overcoming drug resistance and improving treatment efficacy in OSCC. Further mechanistic studies and in vivo validation are warranted to explore its translational relevance in clinical oncology.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: